CN109106931A - A kind of drug and preparation method thereof for treating intractable renal edema - Google Patents
A kind of drug and preparation method thereof for treating intractable renal edema Download PDFInfo
- Publication number
- CN109106931A CN109106931A CN201810967098.6A CN201810967098A CN109106931A CN 109106931 A CN109106931 A CN 109106931A CN 201810967098 A CN201810967098 A CN 201810967098A CN 109106931 A CN109106931 A CN 109106931A
- Authority
- CN
- China
- Prior art keywords
- parts
- drug
- product
- treatment
- production method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of drug and preparation method thereof for treating intractable renal edema, the drug is mainly made by ramulus cinnamomi, Radix Paeoniae Alba, ginger, fennel seeds, Rhizoma Chuanxiong, asarum, pheretima, rhizoma zingiberis and Chinese yam.Each component has synergistic effect well, ramulus cinnamomi warming meridian, helps yang transforming qi in side, and yin is held back in Radix Paeoniae Alba blood-nourishing, and ginger is warming channel and expelling cold, fennel seeds qi-regulating cold dispelling, Rhizoma Chuanxiong blood-activating and qi-promoting, asarum expelling wind and clearing away cold, pheretima dredging collateral dissolving stasis, rhizoma zingiberis warming meridian, Chinese yam reinforcing spleen and kidney.The effect of all medicines share, plays warming and activating meridian altogether, inducing diuresis for removing edema, can be used for treating intractable renal edema, good effect, and have no drug resistance, without side-effects, reach goal of the invention.
Description
Technical field
The present invention relates to a kind of drugs and preparation method thereof for treating intractable renal edema, belong to field of pharmaceutical technology.
Technical background
Renal edema is because various primary or secondary factors lead to glomerular injury, and filtering function declines, excessive
Liquid oedema caused by tissue interval accumulation.Definition in relation to refractory edema, there is presently no unified to define, usually
Refer to after the treatment such as diuresis or joint diuresis, the oedema not still being clearly better, often betide clinical various nephrosis, heart failure,
Situations such as hepatopathy later period, obstruction of lymphatic return.And renal refractory edema, because to conventional treatment (such as low salt diet, diuresis of reducing swelling
Agent) Low Response, often aggravate trend in progressive, be more one of stubborn problem in Kidney Disease, be common in it is primary or
In the diseases such as secondary Treating Intractable Nephrotic, diabetic nephropathy.Renal refractory edema is mainly shown as double lower limb severe
Pitting edema is difficult to subside notably with ascites or hydrothorax through conventional therapy.And there are many treatment renal edema method now, west
The treatment for this disease is cured, mostly uses the methods of diuresis or joint diuresis greatly, effective blood volume deficiency then supplements blood plasma if it exists
Albumin, D-40 etc. are disappeared using the single superfine therapy measure of blood purification technology progress ultrafiltration treatment dialysis progress
It is swollen.Human serum albumin can be used as one of the drug for using more universal in renal refractory edema treatment means, however because
It is blood product, not only expensive, but also there are the risks such as anaphylactic shock, Hematogenous infection, cross multi input albumin
It can also increase because of Urine proteins discharge rate, cause glomerular epithelium cell to be damaged, i.e. " protein overloading nephrosis ".And low molecule dextrorotation
Sugared acid anhydride can effectively increase blood volume as dextran class drug, to increase kidney perfusion, glomerulus height be caused to filter,
Its adverse reaction should also be drawn attention, and many reports point out that D-40 easily leads to anaphylactic shock, acute kidney damage
Wound is even dead.Though the above therapy can obtain certain curative effect in a short time, side effect is more, and costly, clinically transports
It is prudent with being answered when such therapy.Hemodialysis blood purification treatment is on the one hand larger to patient's damage, on the other hand due to somewhat expensive
It returns patient and brings economy and mental burden.
In addition, clinically still or mainly being treated using diuretics in the treatment method of oedema, but often
Unsatisfactory, many oedema show as intractable, even if Large dosage of diuretics be difficult to subside, or even because serious water
It swells or excessively leads to thromboembolism even renal failure using diuretics, very big puzzlement is brought to clinician.Therefore it seeks
It asks a kind of toxic side effect few and measure of effectively reducing swelling, is the heat subject of current medical personnel.
Summary of the invention:
The object of the present invention is to provide a kind of drugs and preparation method thereof for treating intractable renal edema.The medicine
Object has the effect of warming and activating meridian, inducing diuresis for removing edema, can be used for treating intractable renal edema, good effect, and have no drug resistance, no pair
Effect.
In order to solve the above technical problems, the present invention is implemented with the following technical solutions: a kind of to treat intractable renal edema
Drug, calculate by weight, mainly by 200-280 parts of ramulus cinnamomi, 280-320 parts of Radix Paeoniae Alba, 100-140 parts of ginger, fennel seeds 60-
100 parts, 80-120 parts of Rhizoma Chuanxiong, 40-80 parts of asarum, 80-120 parts of pheretima, 130-170 parts of rhizoma zingiberis and 130-170 parts of Chinese yam production
It forms.
In the drug for the treatment of intractable renal edema above-mentioned, calculate by weight, mainly by 220-260 parts of ramulus cinnamomi, white
290-310 parts of Chinese herbaceous peony, 110-130 parts of ginger, 70-90 parts of fennel seeds, 90-110 parts of Rhizoma Chuanxiong, 50-70 parts of asarum, pheretima 90-110
Part, 140-160 parts of rhizoma zingiberis and 140-160 parts of Chinese yam are made.
In the drug for the treatment of intractable renal edema above-mentioned, calculate by weight, mainly by 240 parts of ramulus cinnamomi, Radix Paeoniae Alba 300
Part, 120 parts of ginger, 80 parts of fennel seeds, 100 parts of Rhizoma Chuanxiong, 60 parts of asarum, 100 parts of pheretima, 150 parts of rhizoma zingiberis and 150 parts of Chinese yam production
It forms.
A kind of production method of the drug for the treatment of intractable renal edema above-mentioned, takes above-mentioned raw materials, customary adjuvant is added,
Auxiliary material can also be not added, processed according to common process, pharmaceutical preparation is made.
In the production method of the drug for the treatment of intractable renal edema above-mentioned, the pharmaceutical preparation is external preparation.
It is above-mentioned treatment intractable renal edema drug production method in, the external preparation be pulvis, ointment,
Patch, tincture, spraying or gelling agent.
In the production method of the drug for the treatment of intractable renal edema above-mentioned, the production method of the pulvis are as follows: take
State drug, after dry, be ground into fine grained to get.
In the production method of the drug for the treatment of intractable renal edema above-mentioned, the production method of the ointment are as follows:
(1) said medicine is taken, the alcohol reflux that 70% is measured with 5-7 times extracts 2-3 times, 0.5-1.5 hours each, extracting solution
Filtering, filtrate recycling ethanol and relative density is the medicinal extract of 1.10-1.12 when being condensed into 50-60 DEG C obtain A product;
(2) sorbierite of the amount of being made 3-5% and the glycerol of 3-5% are taken, is added in A product, being heated to 85-90 DEG C makes to dissolve,
Obtain B product;
(3) the poly- sorb of the stearic acid of the amount of being made 5-7%, the tristearin of 4-6%, the yellow petroleum jelly of 1-3%, 5-7% are separately taken
The sucrose stearate of rouge 80, the lanolin of 0.5-1.5% and 0.5-1.5% is heated to 85-90 DEG C, makes to melt, and obtains C product;
(4) B product and C product mixing and emulsifying 20-30 minutes, 60-70 DEG C heat preservation 50-60 minutes, the amount of being made 0.2-0.5% is added
Benzoic acid and 0.1-0.2% ethyl hydroxy benzoate mix, it is filling to get.
In the production method of the drug for the treatment of intractable renal edema above-mentioned, the production method of the patch are as follows:
(1) said medicine is taken, the alcohol reflux that 70% is measured with 5-7 times extracts 2-3 times, 0.5-1.5 hours each, extracting solution
Filtering, filtrate recycling ethanol and relative density is the medicinal extract of 1.10-1.12 when being condensed into 50-60 DEG C obtain A product;
(2) wool of the rubber of A product weight 30-40%, the rosin of 30-40%, the vaseline of 3-7% and 10-20% is taken
Rouge heating melting obtains B product;
(3) B product are added in A product, and 15-30 is mixed with the glycerol of B product weight amount 5-8% and the zinc oxide of 30-50%
Minute, spice is obtained, will mount material respectively, and medical mylar and spice are fitted into patch spreading equipment, roll, after forming,
Cutting, dispense, sealing, packaging to get.
In the production method of the drug for the treatment of intractable renal edema above-mentioned, the production method of the tincture are as follows: according to
Prescription ratio weighs each raw material, add the 8-12 times of soaking in Chinese liquor measured 30 days or more to get.
Drug of the present invention is mainly by ramulus cinnamomi, Radix Paeoniae Alba, ginger, fennel seeds, Rhizoma Chuanxiong, asarum, pheretima, rhizoma zingiberis and Chinese yam system
It forms.Wherein, ramulus cinnamomi, nature and flavor acrid, sweet, warm;Channel tropism return heart, lung, bladder meridian.Major function sweating expelling pathogenic factors from muscles and skin, warming meridian help
Yang transforming qi, flat gas that spins;For anemofrigid cold, coldness and pain in the epigastrium, blood trembles with fear Amenorrhea, arthralgia, phlegm retention, oedema, palpitaition, renal mass.
Radix Paeoniae Alba, it is bitter in taste, sour, it is slightly cold;Channel tropism returns liver, the spleen channel.Major function calming the liver and relieving pain, nourishing blood for regulating menstruation, astringing YIN to stop sweating;For having a headache
Dizziness, hypochondriac pain, abdominal pain, four limbs contraction pain, blood deficiency chlorosis, irregular menstruation, spontaneous perspiration, night sweat.Ginger, nature and flavor are pungent, tepor;Channel tropism is returned
Lung, spleen, stomach meridian;Major function relieving exterior syndrome and dispelling cold, warming middle energizer to arrest vomiting, preventing phlegm from forming and stopping coughing;For anemofrigid cold, gastrofrigid vomiting, cold phlegm is coughed.It is small
Fennel, nature and flavor are acrid in flavour and warm in nature;Channel tropism returns liver,kidney,spleen, stomach meridian;Major function eliminating cold to stop pain, regulating qi-flowing for harmonizing stomach;For cold hernia stomachache, testis
The ball swelling and hanging down of either of the testes, dysmenorrhea, abdomen crymodynia, abdominal distention, deficiency of food are vomited and diarrhoea, hydrocele testis;Salt fennel seeds warm up kidney eliminating cold to stop pain.For
Cold hernia stomachache, the testis swelling and hanging down of either of the testes, through abdominal pain of trembling with fear.Rhizoma Chuanxiong, nature and flavor are acrid in flavour and warm in nature;Channel tropism returns liver, gallbladder, pericardium channel;Major function promoting blood circulation row
Gas, wind-expelling pain-stopping;For irregular menstruation, amenorrhea and algomenorrhea, abdominal mass abdominal pain, pricking pain in the chest, tumbling and swelling, headache, rheumatic arthralgia.Carefully
Pungent, nature and flavor are acrid in flavour and warm in nature;Channel tropism return heart, lung, kidney channel;Major function expelling wind and clearing away cold, sensible analgesic, warming lung and resolving fluid;For chill sense
It emits, has a headache, toothache, nasosinusitis of having a stuffy nose, rheumatic arthralgia, sputum cough.Pheretima, nature and flavor are salty, tremble with fear.Channel tropism returns liver, spleen, bladder meridian;Function
Heat-clearing arresting convulsion can be cured mainly, dredging collateral is relievingd asthma, diuresis;For unconsciousness due to high fever, twitch, arthralgia, extremity numbness, half body is not
Then, dyspnea and cough due to lung-heat, oliguria oedema, hypertension.Rhizoma zingiberis, nature and flavor are pungent, warm;Channel tropism returns spleen, stomach, kidney, the heart, lung channel;Major function is dry
Ginger warming spleen and stomach for dispelling cold, recover Yang and smooth venation, eliminating dampness dissolving phlegm;For coldness and pain in the epigastrium, vomiting and diarrhea, cold weak pulse of limb, sputum cough.Chinese yam, property
Taste sweet and neutral;Channel tropism returns spleen, lung, kidney channel;Major function tonifying spleen nourishing the stomach, engender liquid and benefic lung, kidney tonifying arresting seminal emission;For spleen eating less, chronic diarrhea
Incessantly, the deficiency syndrome of the lung is breathed with cough, emission due to the kidney deficiency, leukorrhagia, frequent micturition, and abnormal heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) good efficacy to suffering from a deficiency of the kidney.For spleen eating less, diarrhea
Loose stool, leukorrhea.
Drug is made using the above raw material in the present invention, and each component has synergistic effect well, ramulus cinnamomi warming meridian in side,
Yin is held back in helps yang transforming qi, Radix Paeoniae Alba blood-nourishing, and ginger is warming channel and expelling cold, fennel seeds qi-regulating cold dispelling, Rhizoma Chuanxiong blood-activating and qi-promoting, asarum expelling wind and clearing away cold,
Pheretima dredging collateral dissolving stasis, rhizoma zingiberis warming meridian, Chinese yam reinforcing spleen and kidney.The effect of all medicines share, plays warming and activating meridian altogether, inducing diuresis for removing edema,
It can be used for treating intractable renal edema, good effect, and have no drug resistance, it is without side-effects, reach goal of the invention.
Treat example statistics
One, clinical observation:
1, patient's general status
78 intractable renal edema patients, male 32, female 46, the age 18-70 years old, average age 52 ± 5.5.Point
Group, treatment group 41, control group 37, protopathy such as table 1:
Table 1 is grouped situation statistics
Grouping | Treatment group's (example) | Control group (example) |
Chronic nephritis | 15 | 13 |
Diabetic nephropathy | 19 | 18 |
Primary nephrotic syndrome | 7 | 6 |
Except thrombus, embolism person.
2, remedy measures:
2.1 Primary Cares:
2.1.1 general treatment: limit salt is restricted water supply;
2.1.2 it is needed according to the state of an illness conventional using depressor, hormone or immunosuppressor, lipid-loweringing, anticoagulant and support of suiting the medicine to the illness
Treatment;
Decompression selection benazepril hydrochloride, Valsartan and/or Levamlodipine beaylate tablets;Hormone or immunosuppressor
Select oral prednisone acetate or methylprednisolone piece, cyclophosphamide or ciclosporin A or mycophenolate mofetil;Lipid-loweringing selection atropic is cut down
Statin;Anticoagulant selection low molecular weight heparin.Symptomatic treatment selects frusemide intravenous drip 120-140mg/d..
2.1.2.1 blood pressure raising person, give plus use ACEI/ARB or CCB etc., make fluctuation of blood pressure in 140/90mmHg or less;
2.1.2.2 the high person of blood glucose, giving adjustment insulin level makes glycemic control in empty stomach 6-8mmol/L, postprandial 2 hours
Between 12-13mmol/L;
2.2 treatment groups: all patients are in Primary Care plus are applied with Chinese medicine (preparing by embodiment 1) of the present invention, have
Body are as follows: drug of the present invention is modulated into paste with 45-55 DEG C or so of warm water, the drug modulated is spread on into about 2cm on gauze
Gauze is spread on patient's double lower limb, Shuan Shenqu by left and right thickness;There is ascites person to add and spreads on navel (SHENQUE acupoint).Infrared lamp is added to shine
After penetrating 20-30min, waits 5min to wait for that residual temperature disperses and remove gauze.1-2 times daily.
2.3 control group only Primary Care.
3, the course for the treatment of
15d is the observation time limit.
4, observation index
1. observing the situation of change of pretherapy and post-treatment patient's edematous site oedema degree.2. pretherapy and post-treatment twenty-four-hour urine egg
White, twenty-four-hour urine amount, oedema integral variation.Oedema ranking criterion (1): 1 point, ankle and following oedema;2 points, oedema before shin is in
Pitting edema is not referred to by it;3 points, oedema before shin, finger submerged while pressing;4 points, double lower limb and double edema of the upper extremity;5 points, with slurry
Membrane cavity hydrops.
5, evaluation criterion
Effective: the symptoms such as oedema, out of strength are obviously improved, and urine protein content significantly reduces, and urine volume obviously increases, oedema integral
Compared with decreaseing beyond 70% before treatment;Effective: the symptoms such as oedema, out of strength make moderate progress, and urine protein content is reduced, and urine volume is
Increase, decline 30%~70% before oedema integral is relatively treated;Invalid: the symptoms such as oedema, out of strength, urine volume, Urine proteins are unchanged,
Oedema integral is dropped by less than 30% before relatively treating.It is effective to be added up to always effectively with effective.
6, statistical analysis analyzes data using 19.0 statistical software of SPSS.
7, result
7.1 pretherapy and post-treatment twenty-four-hour urine albumen, twenty-four-hour urine amount, oedema integral contrast (table 1)
The pretherapy and post-treatment twenty-four-hour urine albumen of table 2, twenty-four-hour urine amount, oedema integral contrast
Note: compared with before treatment:*P<0.05;Compared with treatment group+P<0.05。
As can be seen from Table 2, twenty-four-hour urine amount before treatment than significantly increasing, twenty-four-hour urine albumen, water using after drug of the present invention
Swollen integral substantially reduces before relatively treating.
7.2 curative effects compare
After treatment, Cure is counted, the results are shown in Table 3.
3 Cure of table statistics
Seen from table 3, drug of the present invention can treat intractable renal edema, curative effect affirmative.
Typical case
Liu, female 38 years old, are diagnosed as nephrotic syndrome, edema of pair of lower extremities, by recess be not easy to restore, abdominal distension is received
Difference, sign of ascites (+) oliguria, color are yellow, (urine volume 500ml/24h or so), routine urinalysis: PRO+++, RBC5-8/HP, for 24 hours Urine proteins
4.2g/L.Through diuresis (frusemide 120mg/d), prednisone acetate tablets take orally (55mg/d) 5 days oedema and aggravate day by day, and urine volume is without bright
Aobvious to increase, after carrying out treatment 5 days using drug of the present invention (being prepared by embodiment 1) in this Primary Care, symptom improves,
Urine volume increases to 1400-1800ml/d and continues to use to symptom after 15 days to be restored completely, and check routine urinalysis: PRO (+) urinates for 24 hours
Albumen 2.11g/L.Subsequent follow-up 1 time weekly, continues 6 months, does not recur.
Mr. Wang, male 29 years old, is diagnosed as diabetic nephropathy, the following oedema of waist, by recess do not rise, hypourocrinia
(400ml/d or so), abdominal distension, nausea, routine urinalysis: PRO++, BLD+, for 24 hours Urine proteins 3.05g/L, by oral administration benazepril hydrochloride
10mgBid decompression, 30R insulin morning 12u, evening 16u subcutaneous injection, gradually dosage is quiet to 140mg/d for oral medicinal herb and frusemide
The arteries and veins drop state of an illness is not relieved.In Primary Care plus with after drug of the present invention (being prepared by embodiment 1) 5 days, hence it is evident that
It improves, urine volume increases to 1000ml/d or so, continues to use to oedema after 10 days and obviously subside, only slight water before double lower limb shin
Swollen, urine volume reaches 2100ml/d, malaise symptoms disappear, and check routine urinalysis: PRO (+), for 24 hours Urine proteins 2.03g/L.Then weekly with
It visits 1 time, continues 6 months, stable disease.
Liu, male 25 years old, are diagnosed as chronic nephritis, double lower limb to thigh root pitting edema, finger submerged while pressing, mind
Fatigue, four limbs burnout, hypourocrinia (600-800ml/24h), routine urinalysis: PRO+++, BLD+, Urine proteins 3.3g/L, passes through for 24 hours
Oral hydrochloride benazepil 10mgQd decompression, oral medicinal herb and frusemide from 80mg/ times gradually dosage to 140mg/d intravenous drip
The state of an illness is not relieved.In this Primary Care, after drug of the present invention (being prepared by embodiment 1) 5 days, hence it is evident that good
Turning, urine volume increases to 1100ml/d or so, and it continues to use to oedema after 10 days and obviously subsides, only Mild edema before double lower limb shin,
Urine volume reaches 2000-2300ml/d, malaise symptoms disappear, and check routine urinalysis: PRO (+), for 24 hours Urine proteins 1.83g/L.Then weekly
Follow-up 1 time, continue 6 months, stable disease.
Compared with prior art, the present invention using ramulus cinnamomi, Radix Paeoniae Alba, ginger, fennel seeds, Rhizoma Chuanxiong, asarum, pheretima, rhizoma zingiberis and
The effect of Chinese yam is made drug, and each component raw material has a good synergistic function, complete square compatibility 5, plays inducing diuresis for removing edema living altogether, can use
In treatment intractable renal edema, good effect, and have no drug resistance, it is without side-effects, reach goal of the invention.
Invention is further described below with reference to embodiment, but is not intended as the foundation limited the present invention.
Specific embodiment:
Embodiment 1.
Formula: ramulus cinnamomi 240g, Radix Paeoniae Alba 300g, ginger 120g, fennel seeds 80g, Rhizoma Chuanxiong 100g, asarum 60g, pheretima 100g,
Rhizoma zingiberis 150g and Chinese yam 150g.
Technique: said medicine is taken to be ground into fine grained after dry to get pulvis.
Usage and dosage: medicinal powder made of the above method is modulated into paste with 45-55 DEG C or so of warm water, by what is modulated
Drug is spread on gauze, and gauze is spread on to the edematous site of patient, after baking 20-30min with infra-red roast light, 5-10min is waited to wait for
Residual temperature, which disperses, removes gauze.1-2 times daily.The course for the treatment of is 7-10 days.
Embodiment 2.
Formula: ramulus cinnamomi 260g, Radix Paeoniae Alba 310g, ginger 130g, fennel seeds 90g, Rhizoma Chuanxiong 110g, asarum 70g, pheretima 110g,
Rhizoma zingiberis 160g and Chinese yam 160g.
Technique: the following steps are included:
(1) said medicine is taken, is extracted 2 times with the alcohol reflux of 6 times of amounts 70%, 1 hour every time, extracting solution filtered, filtrate
The medicinal extract that relative density is 1.10-1.12 when recycling ethyl alcohol and being condensed into 50-60 DEG C, obtains A product;
(2) sorbierite of the amount of being made 4% and 4% glycerol are taken, is added in A product, being heated to 85-90 DEG C makes to dissolve, and obtains B
Product;
(3) stearic acid of the amount of being made 6%, 5% tristearin, 2% yellow petroleum jelly, 6% poly- sorb rouge 80,1% are separately taken
Lanolin and 1% sucrose stearate be heated to 85-90 DEG C, make to melt, obtain C product;
(4) B product and C product mixing and emulsifying 25 minutes, 60-70 DEG C keeps the temperature 55 minutes, be added the amount of being made 0.4% benzoic acid and
0.15% ethyl hydroxy benzoate mixes, filling to get ointment.
Usage and dosage: external application is applied to affected part, and each 4-6h smears primary.
Embodiment 3.
Formula: it ramulus cinnamomi 220g, Radix Paeoniae Alba 290g, ginger 110g, fennel seeds 70g, Rhizoma Chuanxiong 90g, asarum 50g, pheretima 90g, does
Ginger 140g and Chinese yam 140g.
Technique: the following steps are included:
(1) said medicine is taken, is extracted 2 times with the alcohol reflux of 6 times of amounts 70%, 1 hour every time, extracting solution filtered, filtrate
The medicinal extract that relative density is 1.10-1.12 when recycling ethyl alcohol and being condensed into 50-60 DEG C, obtains A product;
(2) 35% rubber of A product weight, 35% rosin, 5% vaseline and 15% lanolin heating melting are taken,
Obtain B product;
(3) B product are added in A product, are mixed 23 minutes with the glycerol of B product weight amount 6% and 40% zinc oxide, obtain medicine
Material, will mount material respectively, and medical mylar and spice are fitted into patch spreading equipment, roll, and after forming, cut, packing,
Sealing is packed to get patch.
Usage and dosage: external application is applied to affected part, and each 4-6h smears primary.
Claims (10)
1. a kind of drug for treating intractable renal edema, it is characterised in that: calculate by weight, mainly by ramulus cinnamomi 200-280
Part, 280-320 parts of Radix Paeoniae Alba, 100-140 parts of ginger, 60-100 parts of fennel seeds, 80-120 parts of Rhizoma Chuanxiong, 40-80 parts of asarum, pheretima
80-120 parts, 130-170 parts of rhizoma zingiberis and 130-170 parts of Chinese yam are made.
2. the drug for the treatment of intractable renal edema as described in claim 1, it is characterised in that: calculate by weight, mainly
By 220-260 parts of ramulus cinnamomi, 290-310 parts of Radix Paeoniae Alba, 110-130 parts of ginger, 70-90 parts of fennel seeds, 90-110 parts of Rhizoma Chuanxiong, asarum
50-70 parts, 90-110 parts of pheretima, 140-160 parts of rhizoma zingiberis and 140-160 parts of Chinese yam are made.
3. the drug for the treatment of intractable renal edema as claimed in claim 2, it is characterised in that: calculate by weight, mainly
By 240 parts of ramulus cinnamomi, 300 parts of Radix Paeoniae Alba, 120 parts of ginger, 80 parts of fennel seeds, 100 parts of Rhizoma Chuanxiong, 60 parts of asarum, 100 parts of pheretima, rhizoma zingiberis
150 parts and 150 parts of Chinese yam are made.
4. a kind of production method of the drug for the treatment of intractable renal edema as claimed in any one of claims 1-3, special
Sign is: taking above-mentioned raw materials, auxiliary material is added, or auxiliary material is not added, is processed according to common process, pharmaceutical preparation is made.
5. the production method of the drug for the treatment of intractable renal edema as claimed in claim 4, it is characterised in that: the medicine
Object preparation is external preparation.
6. the production method of the drug for the treatment of intractable renal edema as claimed in claim 5, it is characterised in that: described outer
It is pulvis, ointment, patch, tincture, spraying or gelling agent with preparation.
7. the preparation method of the drug for the treatment of intractable renal edema as claimed in claim 6, it is characterised in that: the pulvis
Production method are as follows: take said medicine, after dry, be ground into fine grained to get.
8. the production method of the drug for the treatment of intractable renal edema as claimed in claim 6, it is characterised in that: the ointment
The production method of agent are as follows:
(1) said medicine is taken, the alcohol reflux that 70% is measured with 5-7 times extracts 2-3 times, 0.5-1.5 hours each, extracting solution mistake
Filter, filtrate recycling ethanol and relative density is the medicinal extract of 1.10-1.12 when being condensed into 50-60 DEG C obtain A product;
(2) sorbierite of the amount of being made 3-5% and the glycerol of 3-5% are taken, is added in A product, being heated to 85-90 DEG C makes to dissolve, and obtains B
Product;
(3) separately take the stearic acid of the amount of being made 5-7%, the tristearin of 4-6%, the yellow petroleum jelly of 1-3%, 5-7% poly- sorb rouge 80,
The lanolin of 0.5-1.5% and the sucrose stearate of 0.5-1.5% are heated to 85-90 DEG C, make to melt, and obtain C product;
(4) B product and C product mixing and emulsifying 20-30 minutes, 60-70 DEG C heat preservation 50-60 minutes, the benzene of the amount of being made 0.2-0.5% is added
The ethyl hydroxy benzoate of formic acid and 0.1-0.2% mix, it is filling to get.
9. the production method of the drug for the treatment of intractable renal edema as claimed in claim 6, it is characterised in that: the patch
Production method are as follows:
(1) said medicine is taken, the alcohol reflux that 70% is measured with 5-7 times extracts 2-3 times, 0.5-1.5 hours each, extracting solution mistake
Filter, filtrate recycling ethanol and relative density is the medicinal extract of 1.10-1.12 when being condensed into 50-60 DEG C obtain A product;
(2) lanolin of the rubber of A product weight 30-40%, the rosin of 30-40%, the vaseline of 3-7% and 10-20% is taken to add
Heat fusing obtains B product;
(3) B product are added in A product, are mixed 15-30 minutes with the glycerol of B product weight amount 5-8% and the zinc oxide of 30-50%,
Spice is obtained, will mount material respectively, and medical mylar and spice are fitted into patch spreading equipment, roll, after forming, cutting,
Packing, sealing, packaging to get.
10. the production method of the drug for the treatment of intractable renal edema as claimed in claim 6, it is characterised in that: the tincture
The production method of agent are as follows: weigh each raw material according to prescription ratio, add the 8-12 times of soaking in Chinese liquor measured 30 days or more to get.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810967098.6A CN109106931B (en) | 2018-08-23 | 2018-08-23 | Medicine for treating intractable renal edema and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810967098.6A CN109106931B (en) | 2018-08-23 | 2018-08-23 | Medicine for treating intractable renal edema and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109106931A true CN109106931A (en) | 2019-01-01 |
CN109106931B CN109106931B (en) | 2021-08-24 |
Family
ID=64860849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810967098.6A Active CN109106931B (en) | 2018-08-23 | 2018-08-23 | Medicine for treating intractable renal edema and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109106931B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012021035A2 (en) * | 2010-08-13 | 2012-02-16 | 한국한의학연구원 | Composition for preventing and treating diabetes complications containing litsea japonica extract or fraction thereof as active ingredient |
CN103549072A (en) * | 2013-10-13 | 2014-02-05 | 太仓市伟基生物科技有限公司 | Vital energy-benefiting brain-boosting tea and preparation method thereof |
CN104337884A (en) * | 2013-08-06 | 2015-02-11 | 颜明 | Medicine composition for preventing and/or treating diabetes and complication of diabetes |
CN107137508A (en) * | 2017-05-09 | 2017-09-08 | 王景文 | It is a kind of to treat medicine of hemorrhoid and preparation method thereof |
-
2018
- 2018-08-23 CN CN201810967098.6A patent/CN109106931B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012021035A2 (en) * | 2010-08-13 | 2012-02-16 | 한국한의학연구원 | Composition for preventing and treating diabetes complications containing litsea japonica extract or fraction thereof as active ingredient |
CN104337884A (en) * | 2013-08-06 | 2015-02-11 | 颜明 | Medicine composition for preventing and/or treating diabetes and complication of diabetes |
CN103549072A (en) * | 2013-10-13 | 2014-02-05 | 太仓市伟基生物科技有限公司 | Vital energy-benefiting brain-boosting tea and preparation method thereof |
CN107137508A (en) * | 2017-05-09 | 2017-09-08 | 王景文 | It is a kind of to treat medicine of hemorrhoid and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
方朝晖: "《中西医结合内分泌代谢疾病诊治学》", 31 March 2013, 中国中医药出版社 * |
杜治宏等: "中西医结合治疗肾性顽固性水肿50例", 《现代中医药》 * |
Also Published As
Publication number | Publication date |
---|---|
CN109106931B (en) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205107B (en) | Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof | |
CN104815099A (en) | Traditional Chinese medicine preparation for treating nearsightedness of teenagers | |
CN102772781A (en) | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof | |
CN101757591B (en) | Traditional Chinese medicine composition for treating chronic colitis and protitis | |
CN104857210A (en) | Traditional Chinese medicine combination preparation for treating fatty liver and preparation method thereof | |
CN104784538A (en) | Chinese medicinal preparation for treating diabetes and preparation method | |
CN101897933A (en) | Chinese patent medicament for treating leucoderma | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN109106931A (en) | A kind of drug and preparation method thereof for treating intractable renal edema | |
CN104383152A (en) | Traditional Chinese medicine preparation for treating glaucoma and preparation method of traditional Chinese medicine preparation | |
CN107468849A (en) | A kind of medicine for treating chronic renal failure and preparation method thereof | |
CN109350711A (en) | A kind of combined traditional Chinese medicine preparation that treating diabetes and preparation method | |
CN109420039A (en) | A kind of Chinese medicine treated diabetes and merge hypoglycemia | |
CN105477384A (en) | Traditional Chinese medicine composition capable of reducing blood pressure and preparation method of composition | |
CN104784567B (en) | A kind of pharmaceutical composition for the treatment of urinary system infection | |
CN118121647A (en) | Traditional Chinese medicine composition for treating chronic heart failure qi deficiency and blood stasis water retention internal arrest syndrome and application thereof | |
CN104491416A (en) | Traditional Chinese medicine composition used for treating diabetes | |
CN104706942A (en) | Medicine composition for treating cerebrocardiac syndrome and preparation method of medicine composition | |
CN103330896A (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
CN104547695B (en) | It is a kind of for treating the pharmaceutical composition and its application of trigeminal neuralgia | |
CN104666926A (en) | Hypertension improving agent | |
CN104127709A (en) | Traditional Chinese medicinal composition for curing chronic renal insufficiency | |
CN103301374A (en) | Pharmaceutical composition for treating postpartum non-specificity vaginitis | |
CN103893448A (en) | Medicine for treating fundus hemorrhage and preparation method thereof | |
CN103285360A (en) | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |